Role of constitutional Homoeopathic Medicine in treatment of Sickle Cell Disease

ROLE OF CONSTITUTIONAL HOMOEOPATHIC MEDICINE IN TREATMENT OF SICKLE CELL DISEASE - NA

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/054782

Enrollment

Registered

2023-07-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D70-D77- Other disorders of blood and blood-forming organs Health Condition 2: D571- Sickle-cell disease without crisis

Interventions

Intervention1: Homoeopathic Constitutional Medicine: Dose: 200, 1M potency Route: Oral (Sub-lingual) Administration Duration: 6-9 Months Control Intervention1: Not Applicable: Not Applicable

Eligibility

Inclusion criteria

Inclusion criteria: Above 18 years age New diagnosed and pre - diagnosed cases of SCD Both sexes. Samples are selected according to sickling positive blood test and clinical signs of individual patient. Those subjects whose willing take part in the study and sign the written informed consent.

Exclusion criteria

Exclusion criteria: Cases which Suffering from other severe systemic diseases. Acute crisis where hospitalization required Pregnant & lactating woman Cases with Irreversible pathologies Irregular follow ups

Design outcomes

Primary

Measure	Time frame
Improvement in Blood indices including Hb% MCV MCHTimepoint: 3 Months	—

Secondary

Measure	Time frame
VAS Scale (Visual Analogue Scale) AssessmentTimepoint: 3, 6, 9 Months	—

Countries

India

Contacts

Public ContactDr Partha Sarthi Mandal

Jawaharlal Nehru Homoeopathic Medical College

mandalpartha58@gmail.com9375095471

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026